Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Heidelberg Pharma shareholders approved all proposals at the 2026 AGM with ~98.7% majority. Jack Yefei Ling joins the Supervisory Board as the company advances its Amanitin-based ADC cancer therapy pipeline. #Biotech #Oncology
2026-06-30T00:01:47.825Z